| |
| |
|
| Insider
Information: |
Mckew John C. |
| Relationship: |
Chief Scientific Officer |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
12,653 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$54,914 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
12,653 |
|
|
| Total
Value |
$54,914 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
aTyr Pharma Inc |
LIFE |
|
|
0 |
|
0 |
Premium* |
|
|
Lumos Pharma Inc |
LUMO |
Chief Scientific Officer |
2024-08-06 |
12,653 |
2020-04-01 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
23 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| LUMO |
Lumos Pharma Inc |
Chief Scientific Officer |
• – – |
2020-04-01 |
4 |
A |
$0.00 |
$0 |
D/D |
13,000 |
13,000 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
Chief Scientific Officer |
• – – |
2021-02-01 |
4 |
A |
$0.00 |
$0 |
D/D |
1,078 |
14,262 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
Chief Scientific Officer |
• – – |
2021-08-01 |
4 |
A |
$0.00 |
$0 |
D/D |
20,000 |
33,226 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
Chief Scientific Officer |
• – – |
2021-09-08 |
4 |
AS |
$11.30 |
$25,018 |
D/D |
(2,214) |
31,012 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
Chief Scientific Officer |
• – – |
2022-02-01 |
4 |
A |
$10.02 |
$15,030 |
D/D |
1,500 |
32,621 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
Chief Scientific Officer |
• – – |
2022-02-01 |
4 |
D |
$10.02 |
$1,002 |
D/D |
(100) |
32,521 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
Chief Scientific Officer |
• – – |
2022-04-01 |
4 |
D |
$9.23 |
$9,562 |
D/D |
(1,036) |
31,485 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
Chief Scientific Officer |
• – – |
2022-04-05 |
4 |
AS |
$8.32 |
$18,420 |
D/D |
(2,214) |
29,271 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
Chief Scientific Officer |
• – – |
2022-06-06 |
4 |
AS |
$7.62 |
$1,288 |
D/D |
(169) |
29,102 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
Chief Scientific Officer |
• – – |
2022-08-01 |
4 |
D |
$8.17 |
$13,015 |
D/D |
(1,593) |
28,009 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
Chief Scientific Officer |
• – – |
2022-08-02 |
4 |
AS |
$8.11 |
$27,631 |
D/D |
(3,407) |
24,602 |
0 |
% |
|
| LUMO |
Lumos Pharma Inc |
Chief Scientific Officer |
• – – |
2023-02-01 |
4 |
D |
$3.52 |
$725 |
D/D |
(206) |
26,896 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
Chief Scientific Officer |
• – – |
2023-02-01 |
4 |
A |
$3.52 |
$7,040 |
D/D |
2,000 |
27,102 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
Chief Scientific Officer |
• – – |
2023-02-02 |
4 |
AS |
$3.53 |
$1,550 |
D/D |
(439) |
26,457 |
0 |
% |
|
| LUMO |
Lumos Pharma Inc |
Chief Scientific Officer |
• – – |
2023-08-01 |
4 |
D |
$3.28 |
$5,225 |
D/D |
(1,593) |
22,114 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
Chief Scientific Officer |
• – – |
2023-08-02 |
4 |
AS |
$3.21 |
$10,919 |
D/D |
(3,407) |
18,707 |
0 |
% |
|
| LUMO |
Lumos Pharma Inc |
Chief Scientific Officer |
• – – |
2024-02-01 |
4 |
D |
$3.01 |
$1,102 |
D/D |
(366) |
18,841 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
Chief Scientific Officer |
• – – |
2024-02-06 |
4 |
AS |
$3.03 |
$1,328 |
D/D |
(438) |
18,403 |
0 |
% |
|
| LUMO |
Lumos Pharma Inc |
Chief Scientific Officer |
• – – |
2024-04-01 |
4 |
A |
$2.84 |
$5,680 |
D/D |
2,000 |
20,403 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
Chief Scientific Officer |
• – – |
2024-04-01 |
4 |
D |
$2.84 |
$2,942 |
D/D |
(1,036) |
19,367 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
Chief Scientific Officer |
• – – |
2024-04-03 |
4 |
AS |
$2.78 |
$6,144 |
D/D |
(2,214) |
17,153 |
0 |
% |
|
| LUMO |
Lumos Pharma Inc |
Chief Scientific Officer |
• – – |
2024-08-01 |
4 |
D |
$1.79 |
$2,851 |
D/D |
(1,593) |
16,060 |
0 |
- |
|
| LUMO |
Lumos Pharma Inc |
Chief Scientific Officer |
• – – |
2024-08-06 |
4 |
AS |
$1.89 |
$6,426 |
D/D |
(3,407) |
12,653 |
0 |
% |
|
23 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
